During the past decade, Unite d'Oncogenetique et de Prevention des Cancers conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unite d'Oncogenetique et de Prevention des Cancers" #1 collaborator was "Chungnam National University" with 1 trials as a collaborator, "Department of Computer Science Yonsei University, Seoul, Korea" with 1 trials as a collaborator, "Ente Ospedaliero Cantonale, Ticino, Switzerland" with 1 trials as a collaborator, "Hopital du Jura, Delemont, Switzerland" with 1 trials as a collaborator and "National Cancer Center, Korea" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Unite d'Oncogenetique et de Prevention des Cancers" are "Breast Cancer" (1 trials), "Hereditary Breast and Ovarian Cancer" (1 trials), "Hereditary Cancer" (1 trials), "Lynch Syndrome" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Unite d'Oncogenetique et de Prevention des Cancers" in a lesser frequency.

Most popular intervention types in "Unite d'Oncogenetique et de Prevention des Cancers" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adapted Family Gene Toolkit" (1 trials), "CASCADE genetic screening" (1 trials) and "Targeted intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unite d'Oncogenetique et de Prevention des Cancers" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Unite d'Oncogenetique et de Prevention des Cancers". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Unite d'Oncogenetique et de Prevention des Cancers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Unite d'Oncogenetique et de Prevention des Cancers, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".